Viral Vector Manufacturing Market: Insights into the Rapidly Expanding Landscape
Introduction:The viral vector manufacturing market is witnessing remarkable growth due to the increasing demand for gene therapy and vaccine development. According to a recent report by MarketsandMarkets, The global viral vector manufacturing market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2% during the forecast period of 2023 to 2028.. This article...
Current Research: Viral Vector Manufacturing Market Major Manufacturers, Trends, Demand, Analysis, and Forecasts to 2023
The base year considered for the study is 2017 and the forecast for the market size is provided for the period between 2018 and 2023.
[107 Pages Report] The global viral vector manufacturing market was valued at USD 273.2 million in 2017 and is expected to grow at a CAGR of 20.0% during the forecast period to reach to USD 815.8 million by 2023.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89341986
Research...
Lonza (Switzerland), Merck (Germany) and Oxford BioMedica (UK) are top players in Viral Vector Manufacturing Market
The global viral vector manufacturing market is projected to reach USD 815.8 million by 2023 from USD 327.8 million in 2018, at a CAGR of 20.0% during the forecast period. This market is consolidated in nature with a few global players. In 2017, Lonza (Switzerland), Merck (Germany), and Oxford BioMedica (UK), were the top three players in the viral vector manufacturing market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89341986
Lonza...
Viral Vector Manufacturing Market Driven by Rising Prevalence of Genetic Disorders, Cancer, and Infectious Diseases
The viral vector manufacturing market is projected to reach USD 815.8 million by 2023 from USD 327.8 million in 2018, at a CAGR of 20.0%. Rising prevalence of target diseases, availability of funding for gene therapy development, effectiveness of viral vectors in gene therapy delivery, and ongoing research into viral vector-based gene therapies are the major drivers of this market.
Download FREE Brochure...